Instil Bio Inc (TIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -37,738 | -6,522 | N/A | N/A |
| Depreciation Amortization | 256 | 20 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,054 | 309 | N/A | N/A |
| Other Working Capital | 1,475 | 366 | N/A | N/A |
| Other Operating Activity | 7,445 | 534 | 0 | 0 |
| Operating Cash Flow | $-29,616 | $-5,293 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -50,816 | -210 | N/A | N/A |
| Net Acquisitions | -306 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -550 | 0 | 0 |
| Investing Cash Flow | $-51,122 | $-760 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 365 | N/A | N/A | N/A |
| Other Financing Activity | 312,683 | 14,948 | 0 | 0 |
| Financing Cash Flow | $313,048 | $14,948 | $N/A | $N/A |
| Exchange Rate Effect | 559 | N/A | N/A | N/A |
| Beginning Cash Position | 8,895 | N/A | N/A | N/A |
| End Cash Position | 241,764 | 8,895 | N/A | N/A |
| Net Cash Flow | $232,869 | $8,895 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -29,616 | -5,293 | N/A | N/A |
| Capital Expenditure | -50,816 | -210 | N/A | N/A |
| Free Cash Flow | -80,432 | -5,503 | 0 | 0 |